Clin2
NCT07389018Possibly a fitNot yet recruiting

Wearable sensors for tracking progressive supranuclear palsy

Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R)

Part of Brain & nervous system clinical trials.

This study tests whether wearable sensors on the ankles can help monitor walking and movement in people with progressive supranuclear palsy (PSP), a brain condition that affects balance and movement. It may help doctors better track the disease over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 40 years old or older
  • You have been diagnosed with possible or probable PSP-Richardson syndrome, a type of PSP
  • You can walk at least 10 meters (about 33 feet) without help from another person
  • You are willing and able to give consent, or have a caregiver who can sign for you if hand movement makes it hard
  • You have a caregiver who can support you during the study
  • You have not had surgery or injury to your legs in the last 6 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07074119Not yet recruiting
Wearable sensors to improve Parkinson's treatment

This trial tests whether using wearable sensors can help doctors adjust Parkinson's medications more precisely to reduce motor fluctuations (times when symptoms worsen or improve unpredictably). It might help you have more stable symptom control throughout the day.

Paris, Île-de-France Region
NCT04753320Not yet recruiting
Remote monitoring for movement disorders

This study tests how well remote monitoring tools, like wearable devices, can track symptoms in people with movement disorders like PSP, Parkinson's disease, or MSA. The goal is to see if these tools can help doctors better understand how the disease progresses from home.

Baltimore, Maryland
NCT07264283Enrolling by invitation· Phase 2
Testing LM11A-31 for progressive supranuclear palsy

This trial tests a drug called LM11A-31 to see if it can help people with progressive supranuclear palsy (PSP), a rare brain condition. You may join if you have had symptoms for 5 years or less, can walk with minimal help, and have good thinking abilities.

San Francisco, California
NCT07173803Recruiting· Phase 2
PSP clinical trial testing new treatments

This trial tests potential new treatments for progressive supranuclear palsy (PSP), a brain disorder affecting movement, balance, and thinking. It aims to see if these treatments are safe and slow the disease. You may be able to join if you have a specific type of PSP and are in fairly good health.

Sun City, Arizona
NCT07240805Not yet recruiting
Digital health tools for monitoring PSP and Lewy body dementia

This study is testing whether digital health tools (like wearable sensors) can better track symptoms of certain brain conditions (PSP, DLB, and MCI with Lewy bodies). It aims to improve monitoring and care for people with these conditions.

Lutherville, Maryland
NCT04468932Recruiting
TMS brain stimulation for progressive supranuclear palsy

This trial tests whether repeated non-invasive magnetic brain stimulation (TMS) can improve symptoms in people with progressive supranuclear palsy (PSP). It may help by targeting brain circuits involved in movement and balance.

Portland, Oregon

Hear when a new Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.